InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (7 ops.)
Explore the full record of transactions filed by Caforio Giovanni, Chairman & CEO. Officer active across 2 companies, notably Bristol Myers Squibb Co. Cumulatively, 9 filings have been published. Total volume traded: €10.4m. The latest transaction was filed on 13 June 2022 (Cession). Regulator: SEC (Form 4). All data is free.
Declarations9 total
€2m30,000 shares@ €71.088820.5% of flow
Common Stock, $0.10 par value
SEC:0000014272-22-000126:0·
0693 shares0
Common Stock
SEC:0000310764-22-000077:0·
€2m25,000 shares@ €64.764215.5% of flow
Common Stock, $0.10 par value
SEC:0000014272-22-000092:0·
018,726 shares0
Common Stock, $0.10 par value
SEC:0000014272-22-000079:0·
€2m30,000 shares@ €59.262217.1% of flow
Common Stock, $0.10 par value
SEC:0000014272-22-000053:0·
€1m25,000 shares@ €51.695652.8% of flow
Common Stock, $0.10 par value
SEC:0000014272-21-000204·
€1m25,000 shares@ €51.695612.4% of flow
Common Stock, $0.10 par value
SEC:0000014272-21-000204:0·
€1m20,000 shares@ €57.753347.2% of flow
Common Stock, $0.10 par value
SEC:0000014272-21-000200·
€1m20,000 shares@ €57.753311.1% of flow
Common Stock, $0.10 par value
SEC:0000014272-21-000200:0·
9 of 9 declarations
About Caforio Giovanni
Giovanni Caforio is the Chairman and CEO of Bristol Myers Squibb Co. and Stryker Corp. He leads these companies with a strategic vision focused on innovation in the pharmaceutical and medical sectors. His leadership is crucial for growth and the development of new treatments.
